It has been recently suggested that TGF-β can interact with other signaling pathways, including those mediated by EGFR, to modulate a variety of cellular responses [68].This kind of signaling crosstalk is a promising area for targeted therapeutic interventions, especially in cancer treatment where the regulation of cell growth and survival is fundamental [29,68]. The gene discussed is TGFB1; the disease is cancer.